SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 408.01 |
| Enterprise Value ($M) | 348.25 |
| Book Value ($M) | 201.42 |
| Book Value / Share | 2.27 |
| Price / Book | 2.03 |
| NCAV ($M) | 197.88 |
| NCAV / Share | 2.23 |
| Price / NCAV | 2.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.08 |
| Return on Assets (ROA) | -0.52 |
| Return on Equity (ROE) | -0.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.05 |
| Current Ratio | 12.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 216.14 |
| Assets | 219.68 |
| Liabilities | 18.26 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 87.37 |
| Operating Income | -291.88 |
| Net Income | -301.74 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -167.65 |
| Cash from Investing | 75.65 |
| Cash from Financing | 0.35 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 7.90 | 51.93 | |
| 13G/A | Panacea Innovation Ltd | 2.60 | -47.62 | |
| 13G | Point72 Asset Management, L.P. | 5.60 | 50.52 | |
| 13G/A | Vanguard Group Inc | 4.53 | 0.00 | |
| 13G | TCG Crossover GP II, LLC | 6.80 | ||
| 13G/A | BlackRock, Inc. | 3.90 | -33.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 114,823 | 936,809 | 12.26 | |
| 375,585 | 2,019,163 | 18.60 | |
| 375,796 | 2,350,884 | 15.99 | |
| 173,374 | 1,133,697 | 15.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALNY – Alnylam Pharmaceuticals, Inc. | ALXO – ALX Oncology Holdings Inc. |
| AMGN – Amgen Inc. | AMPH – Amphastar Pharmaceuticals, Inc. |
| AMRX – Amneal Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io